Research comparing the pathways leading to increased phosphorylation of CRMP2 with those responsible for tau hyperphosphorylation in AD proposed that common mechanisms, such as elevated kinase activity or diminished phosphatase function, may be involved (Soutar et al., 2009). The gene discussed is MAPT; the disease is Alzheimer disease.